The Coronavirus Is No Match Against Sybody 23

The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 receptor. Unsurprisingly, stopping the spike protein from latching on to ACE2 has been a major focus in the design and development of COVID-19 therapeutics.

One such approach is by using antibodies (natural immune molecules that attach to pathogens) which have proven to be…



Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
River D'Almeida, Ph.D

Follow me for bite-sized stories on the latest discoveries and innovations in biomedical research.